UK markets open in 1 hour 42 minutes
NIKKEI 225
37,698.09 -761.99 (-1.98%) HANG SENG
17,244.43 +43.16 (+0.25%) CRUDE OIL
82.95 +0.14 (+0.17%) GOLD FUTURES
2,328.70 -9.70 (-0.41%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,468.11 -2,176.30 (-4.06%)
TScan Therapeutics, Inc. (TCRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 390.13M |
| Enterprise value | 290.52M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 23.00 |
| Price/book (mrq) | 2.59 |
| Enterprise value/revenue | 13.80 |
| Enterprise value/EBITDA | -3.63 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.90 |
| 52-week change 3 | 237.29% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 9.00 |
| 52-week low 3 | 1.62 |
| 50-day moving average 3 | 7.08 |
| 200-day moving average 3 | 4.69 |
Share statistics
| Avg vol (3-month) 3 | 197.81k |
| Avg vol (10-day) 3 | 316.09k |
| Shares outstanding 5 | 48.59M |
| Implied shares outstanding 6 | 5.14M |
| Float 8 | 21.11M |
| % held by insiders 1 | 0.91% |
| % held by institutions 1 | 78.81% |
| Shares short (28 Mar 2024) 4 | 219.41k |
| Short ratio (28 Mar 2024) 4 | 1.05 |
| Short % of float (28 Mar 2024) 4 | 0.57% |
| Short % of shares outstanding (28 Mar 2024) 4 | 0.46% |
| Shares short (prior month 29 Feb 2024) 4 | 187.73k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -296.17% |
Management effectiveness
| Return on assets (ttm) | -24.79% |
| Return on equity (ttm) | -71.29% |
Income statement
| Revenue (ttm) | 21.05M |
| Revenue per share (ttm) | 0.32 |
| Quarterly revenue growth (yoy) | 133.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -88.1M |
| Net income avi to common (ttm) | -89.22M |
| Diluted EPS (ttm) | -1.36 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 192.04M |
| Total cash per share (mrq) | 4.01 |
| Total debt (mrq) | 92.43M |
| Total debt/equity (mrq) | 61.27% |
| Current ratio (mrq) | 6.51 |
| Book value per share (mrq) | 3.15 |
Cash flow statement
| Operating cash flow (ttm) | -61.36M |
| Levered free cash flow (ttm) | -41.83M |
© 2024 Yahoo. All rights reserved.